-
1
-
-
34548720439
-
Pharmacogenetics of the response to beta 2 agonist drugs: A systematic overview of the field
-
Contopoulos-Ioannidis DG, Kouri I, Ioannidis JP. Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field. Pharmacogenomics 2007; 8: 933-958.
-
(2007)
Pharmacogenomics
, vol.8
, pp. 933-958
-
-
Contopoulos-Ioannidis, D.G.1
Kouri, I.2
Ioannidis, J.P.3
-
2
-
-
0033915078
-
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma
-
Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162: 75-80.
-
(2000)
Am J Respir Crit Care Med
, vol.162
, pp. 75-80
-
-
Israel, E.1
Drazen, J.M.2
Liggett, S.B.3
Boushey, H.A.4
Cherniack, R.M.5
Chinchilli, V.M.6
-
3
-
-
0033841788
-
Asthma exacerbations during long term beta agonist use: Influence of beta(2) adrenoceptor polymorphism
-
Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 2000; 55: 762-767.
-
(2000)
Thorax
, vol.55
, pp. 762-767
-
-
Taylor, D.R.1
Drazen, J.M.2
Herbison, G.P.3
Yandava, C.N.4
Hancox, R.J.5
Town, G.I.6
-
4
-
-
6944232728
-
Use of regularly scheduled albuterol treatment in asthma: Genotypestratified, randomised, placebo-controlled cross-over trial
-
Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ et al. Use of regularly scheduled albuterol treatment in asthma: genotypestratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364: 1505-1512.
-
(2004)
Lancet
, vol.364
, pp. 1505-1512
-
-
Israel, E.1
Chinchilli, V.M.2
Ford, J.G.3
Boushey, H.A.4
Cherniack, R.5
Craig, T.J.6
-
5
-
-
0031466866
-
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing
-
Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-3188.
-
(1997)
J Clin Invest
, vol.100
, pp. 3184-3188
-
-
Martinez, F.D.1
Graves, P.E.2
Baldini, M.3
Solomon, S.4
Erickson, R.5
-
6
-
-
20144363204
-
Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma
-
Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005; 171: 563-570.
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 563-570
-
-
Choudhry, S.1
Ung, N.2
Avila, P.C.3
Ziv, E.4
Nazario, S.5
Casal, J.6
-
8
-
-
33645110637
-
Beta-Adrenergic receptor polymorphisms and response to salmeterol
-
Wechsler ME, Lehman E, Lazarus SC, Lemanske Jr RF, Boushey HA, Deykin A et al. Beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006; 173: 519-526.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 519-526
-
-
Wechsler, M.E.1
Lehman, E.2
Lazarus, S.C.3
Lemanske Jr., R.F.4
Boushey, H.A.5
Deykin, A.6
-
9
-
-
33749370049
-
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma
-
Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH et al. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. J Allergy Clin Immunol 2006; 118: 809-816.
-
(2006)
J Allergy Clin Immunol
, vol.118
, pp. 809-816
-
-
Bleecker, E.R.1
Yancey, S.W.2
Baitinger, L.A.3
Edwards, L.D.4
Klotsman, M.5
Anderson, W.H.6
-
10
-
-
37349091262
-
Effect of ADRB2 polymorphisms on response to long acting beta2-agonist therapy: A pharmacogenetic analysis of two randomised studies
-
Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to long acting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 2007; 370: 2118-2125.
-
(2007)
Lancet
, vol.370
, pp. 2118-2125
-
-
Bleecker, E.R.1
Postma, D.S.2
Lawrance, R.M.3
Meyers, D.A.4
Ambrose, H.J.5
Goldman, M.6
-
11
-
-
60649118728
-
Genetic association analysis of COPD candidate genes with bronchodilator responsiveness
-
Kim WJ, Hersh CP, DeMeo DL, Reilly JJ, Silverman EK. Genetic association analysis of COPD candidate genes with bronchodilator responsiveness. Respir Med 2009; 103: 552-557.
-
(2009)
Respir Med
, vol.103
, pp. 552-557
-
-
Kim, W.J.1
Hersh, C.P.2
Demeo, D.L.3
Reilly, J.J.4
Silverman, E.K.5
-
12
-
-
50249109629
-
Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD
-
Mokry M, Joppa P, Slaba E, Zidzik J, Habalova V, Kluchova Z et al. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD. Med Sci Monit 2008; 14: CR392-CR398.
-
(2008)
Med Sci Monit
, vol.14
-
-
Mokry, M.1
Joppa, P.2
Slaba, E.3
Zidzik, J.4
Habalova, V.5
Kluchova, Z.6
-
13
-
-
36349014174
-
Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD
-
Hizawa N, Makita H, Nasuhara Y, Betsuyaku T, Itoh Y, Nagai K et al. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD. Chest 2007; 132: 1485-1492.
-
(2007)
Chest
, vol.132
, pp. 1485-1492
-
-
Hizawa, N.1
Makita, H.2
Nasuhara, Y.3
Betsuyaku, T.4
Itoh, Y.5
Nagai, K.6
-
14
-
-
55949113807
-
Lung function response to 12-week treatment with combined inhalation of longacting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease
-
Kim WJ, Oh YM, Sung J, Kim TH, Huh JW, Jung H et al. Lung function response to 12-week treatment with combined inhalation of longacting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung 2008; 186: 381-386.
-
(2008)
Lung
, vol.186
, pp. 381-386
-
-
Kim, W.J.1
Oh, Y.M.2
Sung, J.3
Kim, T.H.4
Huh, J.W.5
Jung, H.6
-
15
-
-
77954800883
-
Once-daily bronchodilators for chronic obstructive pulmonary disease: Indacaterol versus tiotropium
-
Donohue JF, Fogarty C, Lotvall J, Mahler DA, Worth H, Yorgancioglu A et al. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med 2010; 182: 155-162.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 155-162
-
-
Donohue, J.F.1
Fogarty, C.2
Lotvall, J.3
Mahler, D.A.4
Worth, H.5
Yorgancioglu, A.6
-
16
-
-
79953026850
-
Once-daily indacaterol versus twice-daily salmeterol for COPD: A placebo-controlled comparison
-
Kornmann O, Dahl R, Centanni S, Dogra A, Owen R, Lassen C et al. Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J 2011; 37: 273-279.
-
(2011)
Eur Respir J
, vol.37
, pp. 273-279
-
-
Kornmann, O.1
Dahl, R.2
Centanni, S.3
Dogra, A.4
Owen, R.5
Lassen, C.6
|